Effect of Smoking Status on Monocyte Tissue Factor Activity, Carotid Atherosclerosis and Long-Term Prognosis in Metabolic Syndrome

Kohashi, Keiichi; Nakagomi, Akihiro; Morisawa, Taichirou; Endoh, Ikuko; Kawaguchi, Naomi; Kusama, Yoshiki; Shimizu, Wataru

doi:10.1253/circj.cj-17-0644

Cited by 13 publications

(11 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 8 , 9 Few studies examined the effects of acute CSE on clotting, but circulating tissue factor activity increased levels have been demonstrated after short-term of cigarette smoking. 9 , 10 So, CSE shows increasing prothrombotic biomarkers and might directly promote thrombosis.…”

mentioning

confidence: 99%

Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population

Elkhalifa

2018

SMJ

View full text Add to dashboard Cite

Objectives:To study the effects of heavy cigarette smoking on coagulation (CGG) screening tests and platelet counts (PLTs) in a Sudanese male adults population.Methods:A case control study was conducted at both Kosti and Gabalein towns, Sudan, during October 2016 to May 2017. A 100 adult cigarette smokers were selected and another 100 matched non-smokers were selected as healthy controls. Blood samples were collected in trisodium citrate anti-coagulant for prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR), analyzed using standard methods (co-agulometer machine) and Ethylenediaminetetraacetic acid for the platelet counts, using an automated haematology analyzer (Sysmex, Tokoyo, Japan).Results:The results showed that the mean platelet counts were significantly lower in the smokers (183x103/cmm±64x103/cmm) versus (244x103/cmm±38x103/cmm) in non-smokers, (p<0.000). Pearson correlation analysis suggested a weak negative correlation between platelet counts with the duration of smoking (r= -0.289, p<0.004) and the age of the smokers (r= -0.238, p<0.017). The mean PT and INR were also significantly lower in smokers (12.9±1.2 seconds) compared with the non-smokers (13.7±1.04 seconds, p<0.000), for PT and (0.95±0.09 versus 1.01±0.08, p<0.000) for INR. In contrast, PTT had no significant variation in smokers (30.5±3.8 seconds) and the non-smokers (37.9±4.6 seconds). A p-value>0.05 was considered significant.Conclusion:Cigarette smokers tend to have lower platelet counts, shorter PT, and INR values, compared to non-smokers. Therefore, smoking might be associated with bleeding disorders but further investigations are needed.

show abstract

mentioning

confidence: 99%

Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population

Elkhalifa

2018

SMJ

View full text Add to dashboard Cite

show abstract

“…In a small group of patients with metabolic syndrome (n=301), four groups were identified according to smoking status at entry and at 12 months: never smokers, past smokers, quitters, and persistent smokers. After 12 months of follow-up even a C-IMT regression was observed in never smokers, past smokers and quitters (by -2.78%, -0.33%, and -1.16%, respectively), whereas persistent smokers showed a progression of 33.3% from baseline [12]. Current or even past smoking emerged by multivariate analyses as independent predictors of C-IMTp in many other population-based cohort studies [4,7,8,[13][14][15][16][17][18][19], as well as in patients with hypercholesterolemia [20], type 1 diabetes (T1DM) [21], or cardiovascular disease (CVD) [22].…”

Section: Methodsmentioning

confidence: 91%

Traditional Risk Factors are Causally Related to Carotid Intima-Media Thickness Progression: Inferences from Observational Cohort Studies and Interventional Trials

Frigerio

Werba

Amato

et al. 2020

CPD

View full text Add to dashboard Cite

In the present review, associations between traditional vascular risk factors (VRFs) and carotid intimamedial thickness progression (C-IMTp) as well as the effects of therapies for VRFs control on C-IMTp were appraised to infer causality between each VRF and C-IMTp. Cohort studies indicate that smoking, binge drinking, fatness, diabetes, hypertension and hypercholesterolemia are associated with accelerated C-IMTp. An exception is physical activity, with mixed data. Interventions for the control of obesity, diabetes, hypertension and hypercholesterolemia decelerate C-IMTp. Conversely, scarce information is available regarding the effect of smoking cessation, stop of excessive alcohol intake and management of the metabolic syndrome. Altogether, these data support a causative role of several traditional VRFs on C-IMTp. Shortcomings in study design and/or ultrasonographic protocols may account for most negative studies, which underlines the importance of careful consideration of methodological aspects in investigations using C-IMTp as the outcome.

show abstract

“…Smoking influences all stages of atherosclerotic plaque formation [55,56]. Cigarette smoking is associated with vascular endothelial dysfunction, increased expression of monocyte tissue factor, and oxidative stress due to the increased ROS production and decreased antioxidant defense systems [57,58]. These changes have an important effect on monocyte recruitment.…”

Section: Macrophagesmentioning

confidence: 99%

Macrophage origin, phenotypic diversity, and modulatory signaling pathways in the atherosclerotic plaque microenvironment

Liu¹,

Zhang²,

Sun³

et al. 2021

View full text Add to dashboard Cite

show abstract

Effect of Smoking Status on Monocyte Tissue Factor Activity, Carotid Atherosclerosis and Long-Term Prognosis in Metabolic Syndrome

Cited by 13 publications

References 34 publications

Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population

Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population

Traditional Risk Factors are Causally Related to Carotid Intima-Media Thickness Progression: Inferences from Observational Cohort Studies and Interventional Trials

Macrophage origin, phenotypic diversity, and modulatory signaling pathways in the atherosclerotic plaque microenvironment

Contact Info

Product

Resources

About